Wybranowski Tomasz, Ziomkowska Blanka, Cyrankiewicz Michał, Kruszewski Stefan
Medical Physics Division, Biophysics Department, Collegium Medicum of Nicolaus Copernicus University, Bydgoszcz, Poland.
Gen Physiol Biophys. 2018 Sep;37(6):647-655. doi: 10.4149/gpb_2018017. Epub 2018 Oct 19.
The aim of this study was to investigate the effect of oxidative stress on drug binding affinity, free and bound fraction. The fluorescence anisotropy method was used to examine the interactions of commercial human serum albumin (HSA) and human plasma proteins with ochratoxin A (OTA) or carboxylate form of camptothecin (CPT-C). In-vitro method revealed significant reduction in bound fraction of drugs to HSA oxidized by chloramine T. Oxidative stress was determined by measuring the plasma level of advanced oxidation protein products (AOPP). A significant positive correlation between the AOPP and the plasma free fraction of tested drugs in thirty healthy patients was also found. The oxidative stress monitoring by AOPP is very important for improvement of dosage of drugs highly bound to albumin and with narrow therapeutic index. As a result of severe oxidative stress, the drug pharmacokinetics and therapeutic effects are prone to change. This study highlights the issues of therapeutic drug monitoring and it can explain the behaviour of drugs in pathological situations.
本研究的目的是调查氧化应激对药物结合亲和力、游离和结合分数的影响。采用荧光偏振法研究市售人血清白蛋白(HSA)和人血浆蛋白与赭曲霉毒素A(OTA)或喜树碱羧酸盐形式(CPT-C)之间的相互作用。体外方法显示,被氯胺T氧化的HSA与药物的结合分数显著降低。通过测量血浆中晚期氧化蛋白产物(AOPP)水平来确定氧化应激。在30名健康受试者中还发现AOPP与受试药物的血浆游离分数之间存在显著正相关。通过AOPP监测氧化应激对于调整与白蛋白高度结合且治疗指数窄的药物剂量非常重要。由于严重的氧化应激,药物的药代动力学和治疗效果容易发生变化。本研究突出了治疗药物监测问题,并能解释药物在病理情况下的行为。